ProSomnus Announces Q1 2023 Investor Call and Participation in Upcoming Investor Conferences

3 years ago

PLEASANTON, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (“the Company”) (NASDAQ: OSA), a pioneer in precision medical devices for the…

Smart for Life Releases Video Showcasing New High Protein Ice Cream

3 years ago

Dr. Sasson Moulavi Discusses Benefits of Smart for Life’s Unique New Product CategoryMIAMI, April 26, 2023 (GLOBE NEWSWIRE) -- Smart…

AUM Biosciences to Participate in Inaugural EF Hutton Global Conference

3 years ago

SINGAPORE and BETHESDA, Md., April 26, 2023 (GLOBE NEWSWIRE) -- AUM Biosciences Pte. Ltd. (“AUM”), a global clinical-stage biotechnology company…

ContraFect Announces First Patient Dosed in the Phase 1b/2 Study of Exebacase in Patients with Chronic Prosthetic Joint Infections of the Knee

3 years ago

YONKERS, N.Y., April 26, 2023 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the discovery…

Allied Corp Signs Joint Venture With Blueberries Medical Corp. to Expand Product Offering and Bring Derivative Products to Global Markets

3 years ago

KELOWNA, British Columbia, April 26, 2023 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID), a leading cannabis…

T2 Biosystems Highlights New Clinical Data Presented at the ECCMID 2023 Conference

3 years ago

LEXINGTON, Mass., April 26, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens…

Wave Life Sciences First Quarter 2023 Financial Results Scheduled for May 3, 2023

3 years ago

CAMBRIDGE, Mass., April 26, 2023 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed…

Vericel to Report First-Quarter 2023 Financial Results on May 10, 2023

3 years ago

CAMBRIDGE, Mass., April 26, 2023 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine…

OMNIMED Announces Appointment of Hugh Dodson to Dual Role of Chief Financial Officer & Chief Operating Officer

3 years ago

Dodson to provide strategic guidance to secure new revenue streams, grow presence in value-based healthcare environment Hugh Dodson - CFO…

SAB Biotherapeutics Announces Positive Results from Phase 3 Trial of SAB-185 in Patients with COVID-19 at High-Risk for Severe Complications

3 years ago

SAB-185, a human IgG1 (polyclonal) antibody therapeutic candidate, demonstrated benefit in sustained symptom resolution in patients with Omicron variants of…